Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-Generation Molecular Information Company
Arboretum LifeSciences, Inc., a next-generation molecular information company, launched today with a mission to make precision medicine a reality for some of the most common diseases that impact patients around the world. Founded by leaders in data science from the Broad Institute, Arboretum’s approach integrates AI and genetic testing to expand access to genomic medicine for patients and enable recruitment of genomically profiled patients for clinical research partners.
